Related Topics
Failure of tuberculosis treatment linked to bacterial resilience
Researchers have discovered a new form of altered drug susceptibility—dubbed antibiotic resilience—that enables Mycobacterium tuberculosis to survive antibiotic treatment.
Prenatal micronutrient supplementation could reduce noncommunicable diseases in children
Scaling up prenatal micronutrient supplementation could have population-wide benefits for the next generation.
Wafaie Fawzi, Vikram Patel, John Quackenbush elected to National Academy of Medicine
Harvard Chan School faculty members Wafaie Fawzi, Vikram Patel, and John Quackenbush were elected to the National Academy of Medicine.
Preparing for the next pandemic
Karl Lauterbach, Germany’s federal minister of health, discussed the G7 Pact for Pandemic Readiness at a Harvard Chan School seminar.
A multidisciplinary approach to eradicating malaria
Public health leaders from around the world gathered at Harvard University for a week-long course to learn the latest developments from experts and discuss new strategies for eradicating malaria.
Bringing heart and humanity to hematology
A hematology fellow from Australia, Eddie Cliff, MPH ’22, cares just as deeply about the well-being of his patients as he does about improving health systems as a whole. He’s also a writer published in the New York…
Supporting aging populations worldwide
Experts urge governments and communities to establish systems that support health and productivity for aging populations.
Getting to know … Patience Saaka, MPH ’22
Patience Saaka is a physician from Ghana with a passion for promoting equity in health care and ending gender-based violence.
A call to optimize child health
A new Lancet series focuses on building a holistic global health agenda for improving child and adolescent health and development from before conception to adulthood, and to reduce inequities in access and quality of care.
Opinion: Botswana lab that identified omicron is model for global health goals
The first lab to identify the omicron COVID-19 variant, established by the government of Botswana and Harvard Chan School, is a model of a successful global health response, according to an opinion article.
